Abstract
A very quantitative, destructive-analysis procedure was devised for assaying the 32P activity content of “hot-wall” angioplasty-balloon catheters. These sources, developed and under investigation by Radiance Medical Systems, Inc. (Irvine, CA), are intended for use in the prophylactic inhibition of restenosis following balloon angioplasty in heart-disease patients. The assay was based on performing a physicochemical digestion of the balloon catheter to extract the 32P activity followed by liquid-scintillation (LS) spectrometry of the resultant solutions. Measurement-based corrections were applied for the residual activity remaining in the digested balloon debris and in all of the digestion apparatus. The LS spectrometry, with 3H-standard efficiency tracing, utilized a previously-developed method for resolving the always-present 33P impurity. Initial ionization current measurements on the sources prior to the destructive assays led to the establishment of calibration factors that can be used for subsequent non-destructive radionuclidic measurements on similar balloon-catheter sources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
